Viking Therapeutics (VKTX) Strength Said tied to Release of Abstract on VK2809

March 27, 2019 8:52 AM

Viking Therapeutics (NASDAQ: VKTX) gained pre-market Wednesday after an abstract of its experimental fatty liver disease drug, VK2809, was ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found